CMMB – chemomab therapeutics ltd. - american depositary shares (US:NASDAQ)
Stock Stats
News
Chemomab to Participate in Oppenheimer's Movers in Rare Disease Summit [Yahoo! Finance]
Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit
Oral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab's CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Cholangitis [Yahoo! Finance]
Oral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab’s CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Cholangitis
Chemomab Therapeutics Ltd. (NASDAQ: CMMB) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $11.00 price target on the stock, down previously from $13.00.
Form EFFECT Chemomab Therapeutics
Form POS AM Chemomab Therapeutics
Form SC 13D/A Chemomab Therapeutics Filed by: Mor George Adi
Form SC 13G Chemomab Therapeutics Filed by: Otto Erik
Form 6-K Chemomab Therapeutics For: Nov 18
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.